The Magazine for Sleep Professionals
Wednesday, May 13, 2026
While continuous positive airway pressure (CPAP) is still the gold standard treatment for obstructive sleep apnea (OSA), it is well-established that many patients struggle with long-term adherence and tolerance.1 The literature indicates that CPAP non-compliance rates remain as high as 34% with little improvement over the last two decades.2 As […]
React Health has announced the latest addition to its Rio II family of masks: the Rio II Full Face Mask, which is now available. Designed to enhance patient comfort and compliance with sleep therapy, the Rio II offers a cost-competitive alternative to many leading masks on the market without compromising […]
The advent of home sleep tests (HSTs) has revolutionized the diagnosis and management of sleep disorders, particularly obstructive sleep apnea (OSA). As a sleep doctor, I frequently engage with colleagues and professionals within the sleep industry to discuss the nuances and complexities of interpreting HST results. This article aims to […]
Ognomy Inc., a trailblazing telemedicine platform dedicated to transforming sleep apnea care, proudly announces the successful completion of its Series Seed Preferred financing round, bringing its total funding to over $6.8 million. This funding milestone coincides with the company surpassing 11,000 patients served, marking a pivotal moment in its mission […]
EnsoData and Nonin partner to address the underserved and undiagnosed sleep apnea patient population with a collaborative home sleep apnea testing approach. The partnership will combine the recently FDA-cleared EnsoSleep PPG software as a medical device (SaMD) algorithm with Nonin’s WristOx2® Model 3150 reusable wrist-worn device, offering sleep labs an […]
Atul Malhotra, MD, Peter C. Farrell Presidential Endowed Chair in Pulmonary Medicine at the University of California San Diego School of Medicine and pulmonologist at UC San Diego Health, has been named the recipient of the 2024 Sleep and Respiratory Neurobiology Lifetime Achievement Award by the American Thoracic Society. The […]
Axsome Therapeutics, Inc. announced that it has reached an agreement with Sandoz Inc. (Sandoz) to dismiss the patent litigation related to Axsome’s product Sunosi® (solriamfetol). The litigation, which was pending in the United States District Court for the District of New Jersey, resulted from submission by Sandoz of an Abbreviated New Drug […]
Huxley Medical, a developer of technologies that streamline cardiopulmonary care, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking, chest-worn, sleep apnea diagnostic patch, SANSA. With this clearance, Huxley Medical can move forward to market its device. The patch is a first-of-its-kind, at-home, single-point-of-skin-contact […]
There has been an increasing number of studies looking at orofacial myofunctional therapy (OMT) as a promising adjunctive treatment for obstructive sleep apnea (OSA).1 OMT essentially helps the patient to retrain the muscles around the face, mouth, and tongue to establish correct oral rest posture and functioning of the oral […]
ProSomnus Sleep Technologies announced record revenues for the quarter that ended June 30, 2024, as it formally emerged from reorganization on August 5, 2024. Revenues for the second quarter totaled a record $9.1 million reflecting increasing orders for the Company’s precision intraoral medical devices. These quarterly results reflect a 22% […]
